Key Takeaways
- “Pre-treatment blood tests” are not one fixed package. The order should match the planned medicine, anesthesia, procedure, disease and recent health changes.
- A complete blood count looks at blood cells; chemistry panels assess substances linked to kidney, liver, electrolyte and metabolic function; coagulation tests answer specific bleeding or anticoagulant questions.
- Do not fast unless the ordering team says to. When fasting is required, confirm the hours, whether plain water is allowed and how to handle diabetes medicines.
- Never stop prescription medicine merely to prepare for a test. Give the team a full list of prescriptions, over-the-counter products, vitamins, supplements and the last dose time.
- A foreign report can be clinically useful, but the receiving hospital may repeat tests because the result is old, the condition changed, units/methods differ, or a current local value is required for safe treatment.
- One value outside the printed range does not automatically mean disease or cancellation. The clinician interprets magnitude, trend, symptoms, specimen quality and the decision the test was meant to support.
Content
The phrase “blood tests before treatment” often arrives as a short message: “Please come fasting for labs.” For an international patient, that can create a page of unanswered questions. Which tests? Why again? Can morning medicine be taken? Is coffee allowed? Will one red number cancel the procedure?
The useful answer begins with the decision, not the tube.
Ask what decision each group of tests supports
Common pre-treatment groups include:
- Complete blood count (CBC): red cells, hemoglobin and hematocrit can inform anemia and oxygen-carrying capacity; white cells may contribute to infection or marrow assessment; platelets contribute to bleeding and treatment-safety decisions. A CBC with differential separates major white-cell types [1].
- Chemistry or metabolic tests: electrolytes, glucose, creatinine and other markers help assess fluid/metabolic status and organ function relevant to medicines, contrast, anesthesia or surgery. The exact panel varies.
- Liver-related tests: may affect drug choice, dose or the need for further evaluation, but a panel is not a stand-alone diagnosis.
- Coagulation tests: PT/INR and sometimes aPTT answer particular questions about clotting, liver disease, bleeding history or anticoagulant treatment. PT/INR may be used before a procedure with bleeding risk and to monitor warfarin [2].
- Disease- or treatment-specific tests: examples include infection screening, blood group/antibody screen, pregnancy testing when relevant, tumor or immune markers, thyroid tests, cardiac markers or therapeutic drug levels.
Not every patient needs every item. Broad panels can create incidental abnormalities without improving the planned decision. Ask: What will this result change—go ahead, adjust a dose, correct a problem, request another test or postpone?
Why does the Chinese hospital want to repeat a recent overseas test?
Repetition is reasonable when it answers a new safety question. Typical reasons include:
- the report is outside the hospital’s accepted time window;
- the patient has had fever, bleeding, dehydration, new medicine, transfusion or treatment since the sample;
- the planned treatment requires a value close to the administration or procedure time;
- the report lacks patient identifiers, collection time, units, reference interval, specimen type or laboratory details;
- the assay method or reporting unit is not directly comparable;
- the result is unexpected and needs confirmation;
- the receiving team needs a locally verified baseline for monitoring or an urgent-care pathway.
China’s rules encourage sharing and recognition of suitable test results, but recognition is conditional on quality, clinical need and safety—not a promise that every outside result must be accepted [7]. Ask which tests can be used, which must be repeated and why. This turns “the hospital repeats everything” into an auditable list.
Do I need to fast?
Often, no. A CBC by itself usually requires no special preparation [1]. Some glucose, lipid, metabolic, liver or renal panels may require fasting depending on the exact order and clinical question. MedlinePlus advises fasting only when instructed and notes that the usual period, when required, is often 8–12 hours; the ordering team must give the exact duration [3].
Get these points in writing:
- start and end time of the fast;
- whether plain water is allowed (it commonly is);
- whether coffee, tea, juice, flavored water, gum, smoking, alcohol or exercise are restricted;
- what to do with morning medicines;
- what to do if the patient has diabetes, is pregnant, is frail, or becomes unwell while fasting.
Do not extend the fast “to make the result cleaner.” Unnecessary fasting can itself alter results and create dehydration, dizziness or hypoglycemia. If the patient ate, drank something other than allowed water or exercised against instructions, tell the collector. Do not conceal it; the team can decide whether to proceed or reschedule.
What about regular medicines and supplements?
Do not stop a prescription unless the responsible clinician instructs you. MedlinePlus specifically advises patients not to stop medicines for a fasting test without provider direction [3].
Send a medication list before the appointment that includes:
- generic and brand names;
- strength and dose;
- usual time and last dose;
- anticoagulants, antiplatelets, insulin and diabetes tablets;
- steroids, thyroid medicines, seizure medicines and immunosuppressants;
- over-the-counter pain or cold products;
- vitamins, minerals, herbal products, bodybuilding products and high-dose biotin.
Ask a closed question: “Should I take this named medicine at this dose and time before the draw?” A blanket answer such as “take your usual medicines” may not resolve a warfarin level, therapeutic drug level, cortisol test or diabetes-fasting plan.
Bring the complete report, not a translated list of numbers
A usable outside report should show:
- patient name and another identifier;
- laboratory name;
- specimen collection date and time;
- specimen type where relevant;
- analyte name, result, unit and that laboratory’s reference interval;
- abnormal/critical flags and comments;
- report or verification time;
- method when it matters to comparison.
China’s clinical laboratory rules require reports to include core identifiers, results, units, reference ranges, abnormal-result prompts and timing information, and require privacy protection [5]. Keep the original PDF. A bilingual summary may sit beside it, but should not replace it.
Do not convert units manually and overwrite the original. For example, a glucose result reported in mmol/L is not numerically comparable to mg/dL. Put both the original number and unit into the handover and let the receiving laboratory or clinician confirm conversion.
Why do reference ranges differ?
The printed range belongs to that laboratory, method and population. FDA notes that results are influenced by age, sex, health, food, medicines, preparation, technique and inter-laboratory variation [4]. This is why a result should not be copied into another laboratory’s range.
An “H” or “L” flag means the value is outside a statistical reference interval; it is not a diagnosis. A mildly abnormal stable result may not alter treatment. A value inside the interval may still matter if it changed sharply from the patient’s baseline or conflicts with symptoms.
Clinicians should consider:
- how far the value is from the range;
- whether it is new or trending;
- whether related results support it;
- whether the sample or preparation could distort it;
- what medicine, disease or recent treatment could explain it;
- whether the result crosses the treatment protocol’s own threshold.
Why would the laboratory request another tube?
A redraw can reflect sample quality rather than a new disease. Examples include incorrect patient or tube identification, wrong container, insufficient volume, clotting in an anticoagulated sample, hemolysis, contamination, delayed transport or a result that fails a verification check.
China’s 2025 clinical laboratory quality indicators specifically track wrong specimen type, wrong container, incorrect volume, clotting of anticoagulated specimens, rejection, incorrect reports and timely communication of critical values [6]. In other words, refusing or repeating a poor sample is part of quality control, not automatically evidence that “something terrible was found.”
Ask the reason: clinical change, confirmation, or specimen problem? If the issue was specimen quality, the old value may be unreliable and should not be trended as though it were a valid clinical change.
What happens when a result is abnormal?
The next step may be any of the following:
- proceed without change;
- repeat the same test to confirm;
- add a related test or clinical assessment;
- replace fluid/electrolytes or treat another reversible issue;
- adjust drug dose, anesthesia or procedure timing;
- postpone treatment for safety;
- send the patient for urgent assessment if the value is critical or symptoms are concerning.
A critical value is not simply any red flag on the patient portal. It is a result the laboratory’s policy identifies as potentially life-threatening and requiring rapid clinical notification. China’s current quality indicators define critical values as results suggesting the patient may be near a life-threatening state after technical causes are excluded, requiring immediate recording and reporting to the responsible clinician [6].
Do not wait in a hotel for an email reply if the patient is fainting, confused, breathless, bleeding heavily, having chest pain or otherwise acutely unwell. Symptoms determine the emergency route even before the complete lab interpretation arrives.
Plan the draw around international-patient realities
Before the appointment, confirm the campus, laboratory hours, registration identity, payment route, whether the order is already in the local system, report language and expected result times. Use exactly the same passport spelling across booking, label and report.
At collection, state the patient’s full name and date of birth and watch for correct labeling according to local workflow. Tell staff about fainting during previous draws, difficult venous access, mastectomy/lymph-node surgery, dialysis access, infusion lines, bleeding disorders, allergies to adhesives and any infection precautions.
Afterward, obtain both the result and the decision. “Labs complete” is not the endpoint. Ask who reviews them, by when, how urgent findings will be communicated, and whether treatment is formally cleared.
Medical disclaimer: This guide is general education. The ordering clinician and laboratory must provide the preparation and interpret results in the context of the patient, planned treatment and local protocol. Do not change medicines or delay emergency care based on this article.
FAQ
Can I drink water before a fasting blood test?
Plain water is commonly allowed and can make venous sampling easier, but follow the written instruction for the exact test. Coffee, tea, juice and flavored drinks are not the same as water.
Should I skip my morning tablets?
Not unless the responsible clinician tells you to. Send the exact medicine, dose and usual time and ask for a medicine-by-medicine instruction, especially for diabetes drugs, anticoagulants, steroids and therapeutic drug levels.
Why was my overseas result not accepted?
It may be too old for the decision, lack identifiers/units/reference ranges, use a non-comparable method, or need a current local baseline. Ask for the reason by test rather than assuming all foreign reports are rejected.
Does one result outside the reference range mean treatment is cancelled?
No. The clinician considers the size and trend of the abnormality, symptoms, related values, specimen quality and the treatment protocol. The plan may proceed, change, be confirmed or be postponed depending on that context.
Why did the laboratory say the sample was hemolyzed or clotted?
Cells may have broken during collection/handling, or an anticoagulated tube may have clotted. Either can make some measurements unreliable. A new sample may be needed; this describes the specimen, not necessarily the patient’s condition.
Sources
- MedlinePlus: Complete Blood Count
- MedlinePlus: Prothrombin Time and INR
- MedlinePlus: Fasting for a Blood Test
- US Food and Drug Administration: Tests Used in Clinical Care
- National Health Commission of China: Administrative Measures for Clinical Laboratories
- National Health Commission of China: Clinical Laboratory Quality Indicators (2025)
- National Health Commission of China: Measures for Mutual Recognition of Examination and Test Results